{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:53:00Z","timestamp":1787885580485,"version":"build-2784847793"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.toxlet.2013.06.234","type":"journal-article","created":{"date-parts":[[2013,7,3]],"date-time":"2013-07-03T22:09:05Z","timestamp":1372889345000},"page":"219-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Biomarkers for methotrexate-induced liver injury: Urinary protein profiling of psoriasis patients"],"prefix":"10.1016","volume":"221","author":[{"given":"Rachel P.L.","family":"van Swelm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coby M.M.","family":"Laarakkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Kooijmans-Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke M.G.J.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinde","family":"Masereeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans G.M.","family":"Russel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2013.06.234_bib0005","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jhep.2007.03.017","article-title":"Dangerous liaisons: drug, host and the environment","volume":"46","author":"Aithal","year":"2007","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrrheum.2010.214","article-title":"Hepatotoxicity related to antirheumatic drugs","volume":"7","author":"Aithal","year":"2011","journal-title":"Nature Reviews Rheumatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0015","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1468-3083.2010.03932.x","article-title":"Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic","volume":"25","author":"Barker","year":"2011","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0020","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2036.2006.03047.x","article-title":"Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent","volume":"24","author":"Berends","year":"2006","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0025","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/archderm.143.12.1515","article-title":"Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens","volume":"143","author":"Berends","year":"2007","journal-title":"Archives of Dermatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000329800","article-title":"Obesity and fatty liver are \u2018grease\u2019 for the machinery of hepatic fibrosis","volume":"29","author":"Bosserhoff","year":"2011","journal-title":"Digestive Diseases"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0035","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1365-2133.2011.10657.x","article-title":"Liver fibrosis screening for patients with psoriasis taking methotrexate: a cross-sectional study comparing transient elastography and liver biopsy","volume":"166","author":"Bray","year":"2012","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0040","article-title":"Assessment of methotrexate hepatotoxicity in psoriasis patients: a prospective evaluation of four serum fibrosis markers","author":"Chladek","year":"2012","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0045","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/hep.23931","article-title":"E-cadherin antagonizes transforming growth factor beta1 gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation","volume":"52","author":"Cho","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0050","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s00535-011-0437-3","article-title":"Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with Fibroscan((R))","volume":"46","author":"Ebinuma","year":"2011","journal-title":"Journal of Gastroenterology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0055","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2133.1986.tb02868.x","article-title":"Elevated serum aminoterminal procollagen type III peptide in methotrexate-induced hepatic fibrosis","volume":"114","author":"Fairris","year":"1986","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1373\/clinchem.2006.077834","article-title":"Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry","volume":"53","author":"Fiedler","year":"2007","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0065","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1373\/clinchem.2007.089144","article-title":"Novel serum biomarker candidates for liver fibrosis in hepatitis C patients","volume":"53","author":"Gangadharan","year":"2007","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0070","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cca.2009.02.017","article-title":"Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease","volume":"403","author":"Gressner","year":"2009","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0075","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1478-3231.2009.02070.x","article-title":"Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin","volume":"29","author":"Hartland","year":"2009","journal-title":"Liver International"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0080","first-page":"472","article-title":"Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs \u2013 comparison of drugs and adverse reactions","volume":"35","author":"Helliwell","year":"2008","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0085","doi-asserted-by":"crossref","first-page":"972759","DOI":"10.1155\/2011\/972759","article-title":"Validation of hepascore as a predictor of liver fibrosis in patients with chronic hepatitis C infection","volume":"2011","author":"Kalantari","year":"2011","journal-title":"Hepatitis Research and Treatment"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1442-200X.2010.03253.x","article-title":"Challenges and opportunities for discovery of disease biomarkers using urine proteomics","volume":"53","author":"Kentsis","year":"2011","journal-title":"Pediatrics International"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0095","series-title":"Protein Sequencing and Identification Using Tandem Mass Spectrometry","first-page":"161","author":"Kinter","year":"2000"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0100","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/rheumatology\/kep023","article-title":"Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term high cumulative dose methotrexate therapy","volume":"48","author":"Lindsay","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0105","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3748\/wjg.v10.i11.1600","article-title":"Association of differentially expressed genes with activation of mouse hepatic stellate cells by high-density cDNA microarray","volume":"10","author":"Liu","year":"2004","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0110","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2133.2005.06459.x","article-title":"Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen","volume":"152","author":"Maurice","year":"2005","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0115","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jhep.2009.06.008","article-title":"Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Miele","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"Suppl. 2","key":"10.1016\/j.toxlet.2013.06.234_bib0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1468-3083.2011.03991.x","article-title":"Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity","volume":"25","author":"Montaudie","year":"2011","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nmeth0608-459","article-title":"Iodoacetamide-induced artifact mimics ubiquitination in mass spectrometry","volume":"5","author":"Nielsen","year":"2008","journal-title":"Nature Methods"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jhep.2012.04.025","article-title":"Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population","volume":"57","author":"Poynard","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0135","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1021\/ac026117i","article-title":"Stop and go extraction tips for matrix-assisted laser desorption\/ionization, nanoelectrospray, and LC\/MS sample pretreatment in proteomics","volume":"75","author":"Rappsilber","year":"2003","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0140","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jhep.2007.01.024","article-title":"Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment","volume":"46","author":"Rosenberg","year":"2007","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-0960.2011.00839.x","article-title":"The use of methotrexate in dermatology: a review","volume":"53","author":"Shen","year":"2012","journal-title":"Australasian Journal of Dermatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pan.2012.05.008","article-title":"Alcoholic chronic pancreatitis and liver cirrhosis: coincidence and differences in lifestyle","volume":"12","author":"Spicak","year":"2012","journal-title":"Pancreatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1089-3261(03)00027-8","article-title":"Drug-induced steatohepatitis","volume":"7","author":"Stravitz","year":"2003","journal-title":"Clinics in Liver Disease"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0160","first-page":"1454","article-title":"Drug use and toxicity in psoriatic disease: focus on methotrexate","volume":"35","author":"Taylor","year":"2008","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0165","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1093\/ndt\/gfm170","article-title":"Biomarker discovery with SELDI-TOF MS in human urine associated with early renal injury: evaluation with computational analytical tools","volume":"22","author":"Vanhoutte","year":"2007","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0170","first-page":"1017","article-title":"Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature","volume":"27","author":"Visser","year":"2009","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0175","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2230.2008.02976.x","article-title":"Methotrexate for psoriasis in the era of biological therapy","volume":"33","author":"Warren","year":"2008","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0180","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/B978-0-12-381294-0.00021-3","article-title":"Liquid chromatography\u2013mass spectrometry-based proteomics of Nitrosomonas","volume":"486","author":"Wessels","year":"2011","journal-title":"Methods in Enzymology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/clpt.2009.240","article-title":"Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans","volume":"88","author":"Winnike","year":"2010","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0190","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1464-5491.2010.03093.x","article-title":"High prevalence of diabetes mellitus in patients with liver cirrhosis","volume":"27","author":"Wlazlo","year":"2010","journal-title":"Diabetic Medicine"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0195","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s100670170004","article-title":"Toxicity of methotrexate treatment in psoriasis and psoriatic arthritis \u2013 short- and long-term toxicity in 104 patients","volume":"20","author":"Wollina","year":"2001","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0200","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1007\/s10620-011-1745-4","article-title":"Novel biomarker candidates to predict hepatic fibrosis in hepatitis C identified by serum proteomics","volume":"56","author":"Yang","year":"2011","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.toxlet.2013.06.234_bib0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4254\/wjh.v5.i5.275","article-title":"Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis","volume":"5","author":"Yeo","year":"2013","journal-title":"World Journal of Hepatology"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427413011065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427413011065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T22:37:10Z","timestamp":1563316630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427413011065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0378427413011065"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2013.06.234","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers for methotrexate-induced liver injury: Urinary protein profiling of psoriasis patients","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2013.06.234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}